These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30111253)

  • 21. No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
    Hofmeijer-Sevink MK; Duits P; Rijkeboer MM; Hoogendoorn AW; van Megen HJ; Vulink NC; Denys DA; van den Hout MA; van Balkom AJ; Cath DC
    J Clin Psychopharmacol; 2017 Oct; 37(5):531-539. PubMed ID: 28820746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of smoking-related virtual environments for cue exposure therapy.
    García-Rodríguez O; Pericot-Valverde I; Gutiérrez-Maldonado J; Ferrer-García M; Secades-Villa R
    Addict Behav; 2012 Jun; 37(6):703-8. PubMed ID: 22385732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a Brief Memory Updating Intervention on Smoking Behavior: A Randomized Clinical Trial.
    Germeroth LJ; Carpenter MJ; Baker NL; Froeliger B; LaRowe SD; Saladin ME
    JAMA Psychiatry; 2017 Mar; 74(3):214-223. PubMed ID: 28146243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-cycloserine and cocaine cue reactivity: preliminary findings.
    Price KL; McRae-Clark AL; Saladin ME; Maria MM; DeSantis SM; Back SE; Brady KT
    Am J Drug Alcohol Abuse; 2009; 35(6):434-8. PubMed ID: 20014913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
    Rosenfield D; Smits JAJ; Hofmann SG; Mataix-Cols D; de la Cruz LF; Andersson E; Rück C; Monzani B; Pérez-Vigil A; Frumento P; Davis M; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner CA; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P; Turner C; Otto MW
    J Anxiety Disord; 2019 Dec; 68():102149. PubMed ID: 31698111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual variables related to craving reduction in cue exposure treatment.
    Pericot-Valverde I; García-Rodríguez O; Gutiérrez-Maldonado J; Secades-Villa R
    Addict Behav; 2015 Oct; 49():59-63. PubMed ID: 26047836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.
    Otto MW; Kredlow MA; Smits JAJ; Hofmann SG; Tolin DF; de Kleine RA; van Minnen A; Evins AE; Pollack MH
    Biol Psychiatry; 2016 Aug; 80(4):274-283. PubMed ID: 26520240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation of exposure therapy with post-session administration of D-cycloserine.
    Tart CD; Handelsman PR; Deboer LB; Rosenfield D; Pollack MH; Hofmann SG; Powers MB; Otto MW; Smits JA
    J Psychiatr Res; 2013 Feb; 47(2):168-74. PubMed ID: 23098672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial.
    Yammine L; Kosten TR; Cinciripini PM; Green CE; Meininger JC; Minnix JA; Newton TF
    Medicine (Baltimore); 2018 Jan; 97(2):e9567. PubMed ID: 29480848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcranial Magnetic Stimulation Combined With Nicotine Replacement Therapy for Smoking Cessation: A Randomized Controlled Trial.
    Trojak B; Meille V; Achab S; Lalanne L; Poquet H; Ponavoy E; Blaise E; Bonin B; Chauvet-Gelinier JC
    Brain Stimul; 2015; 8(6):1168-74. PubMed ID: 26590478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of deactivation of activity patterns related to smoking cue reactivity on nicotine addiction.
    Bu J; Young KD; Hong W; Ma R; Song H; Wang Y; Zhang W; Hampson M; Hendler T; Zhang X
    Brain; 2019 Jun; 142(6):1827-1841. PubMed ID: 31135053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
    Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
    Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of varenicline on stress-induced and cue-induced craving for cigarettes.
    Ray LA; Lunny K; Bujarski S; Moallem N; Krull JL; Miotto K
    Drug Alcohol Depend; 2013 Jul; 131(1-2):136-42. PubMed ID: 23298651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.